PCM
Peregrine Capital Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-126,613
| Closed | -$6.34M | – | 341 |
|
|
2021
Q3 | $6.34M | Sell |
126,613
-24,387
| -16% | -$1.22M | 0.13% | 244 |
|
|
2021
Q2 | $9.51M | Sell |
151,000
-5,113
| -3% | -$322K | 0.17% | 238 |
|
|
2021
Q1 | $14.5M | Sell |
156,113
-20,778
| -12% | -$1.93M | 0.27% | 183 |
|
|
2020
Q4 | $15.8M | Buy |
176,891
+30,266
| +21% | +$2.71M | 0.3% | 140 |
|
|
2020
Q3 | $15.2M | Sell |
146,625
-73,463
| -33% | -$7.59M | 0.4% | 96 |
|
|
2020
Q2 | $17.4M | Sell |
220,088
-25,107
| -10% | -$1.99M | 0.49% | 75 |
|
|
2020
Q1 | $14.2M | Sell |
245,195
-52,850
| -18% | -$3.06M | 0.51% | 72 |
|
|
2019
Q4 | $16.1M | Sell |
298,045
-3,442
| -1% | -$186K | 0.41% | 113 |
|
|
2019
Q3 | $15.8M | Sell |
301,487
-22,398
| -7% | -$1.17M | 0.43% | 102 |
|
|
2019
Q2 | $15.6M | Buy |
323,885
+25,799
| +9% | +$1.25M | 0.39% | 114 |
|
|
2019
Q1 | $15.1M | Buy |
298,086
+30,346
| +11% | +$1.53M | 0.38% | 121 |
|
|
2018
Q4 | $15.9M | Sell |
267,740
-42,473
| -14% | -$2.52M | 0.45% | 89 |
|
|
2018
Q3 | $20.4M | Sell |
310,213
-19,407
| -6% | -$1.28M | 0.48% | 86 |
|
|
2018
Q2 | $16.6M | Sell |
329,620
-19,348
| -6% | -$977K | 0.42% | 110 |
|
|
2018
Q1 | $18.4M | Sell |
348,968
-17,202
| -5% | -$906K | 0.45% | 90 |
|
|
2017
Q4 | $17M | Sell |
366,170
-88,687
| -19% | -$4.12M | 0.4% | 101 |
|
|
2017
Q3 | $18.4M | Buy |
454,857
+131,692
| +41% | +$5.33M | 0.44% | 88 |
|
|
2017
Q2 | $11M | Sell |
323,165
-912
| -0.3% | -$30.9K | 0.27% | 154 |
|
|
2017
Q1 | $9.52M | Buy |
324,077
+22,232
| +7% | +$653K | 0.24% | 176 |
|
|
2016
Q4 | $9.91M | Buy |
+301,845
| New | +$9.91M | 0.26% | 179 |
|